We expect Keurig Dr Pepper to generate excess investment returns aided by intangible assets and ... from distribution and procurement consolidation and a leaner organization. We don't expect this ...
Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim ...